Immunotherapy approaches for peanut allergy

References

• Tang ML, Mullins RJ. Food allergy: is prevalence increasing? Intern Med J. 2017;47(3):256–261.
   PubMed Web of Science ®Google Scholar
• Peters RL, Allen KJ, Dharmage SC, et al. Natural history of peanut allergy and predictors of resolution in the first 4 years of life: A population-based assessment. J Allergy Clin Immunol. 2015;135(5):1257-66e1-2.
   Web of Science ®Google Scholar
• Gupta RS, Warren CM, Smith BM, et al. The public health impact of parent-reported childhood food allergies in the United States. Pediatrics. 2018;142(6):e20181235. DOI:10.1542/peds.2018-1235.
   PubMed Web of Science ®Google Scholar
• Sicherer SH, Munoz-Furlong A, Godbold JH, et al. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol. 2010;125(6):1322–1326.
   PubMed Web of Science ®Google Scholar
• Peters RL, Koplin JJ, Gurrin LC, et al. The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: healthNuts age 4-year follow-up. J Allergy Clin Immunol. 2017;140(1):145–53 e8.
   PubMed Web of Science ®Google Scholar
• Turner PJ, Baumert JL, Beyer K, et al. Can we identify patients at risk of life-threatening allergic reactions to food? Allergy. 2016;71(9):1241–1255.
   PubMed Web of Science ®Google Scholar
• Herbert L, Shemesh E, Bender B. Clinical management of psychosocial concerns related to food allergy. J Allergy Clin Immunol Pract. 2016;4(2): 205–213. quiz 14.
   PubMed Web of Science ®Google Scholar
• Gupta R, Holdford D, Bilaver L, et al. The economic impact of childhood food allergy in the United States. JAMA Pediatr. 2013;167(11):1026–1031.
   PubMed Web of Science ®Google Scholar
• D’Auria E, Abrahams M, Zuccotti GV, et al. Personalized nutrition approach in food allergy: is it prime time yet? Nutrients. 2019;11(2):359.
   Web of Science ®Google Scholar
• Fleischer DM, Perry TT, Atkins D, et al. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics. 2012;130(1):e25–32.
   PubMed Web of Science ®Google Scholar
• Vickery BP, Berglund JP, Burk CM, et al. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017;139(1):173–81e8.
   PubMed Web of Science ®Google Scholar
• Kim EH, Bird JA, Kulis M, et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol. 2011;127(3):640–6e1.
   PubMed Web of Science ®Google Scholar
• Jones SM, Sicherer SH, Burks AW, et al. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol. 2017;139(4):1242–52 e9.
   PubMed Web of Science ®Google Scholar
• Sampson HA, Shreffler WG, Yang WH, et al. Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: a randomized clinical trial. JAMA. 2017;318(18):1798–1809.
   PubMed Web of Science ®Google Scholar
• Fleischer DM, Greenhawt M, Sussman G, et al. Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial. JAMA. 2019;321:946–955.
   PubMed Web of Science ®Google Scholar
• Vickery BP, Scurlock AM, Kulis M, et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014;133(2):468–475.
   PubMed Web of Science ®Google Scholar
• Fleischer DM, Burks AW, Vickery BP, et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol. 2013;131(1):119–27e1-7.
   Web of Science ®Google Scholar
• Jones SM, Pons L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol. 2009;124(2):292–300, e1–97.
   Web of Science ®Google Scholar
• Kulis M, Saba K, Kim EH, et al. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol. 2012;129(4):1159–1162.
   PubMed Web of Science ®Google Scholar
• Aguilera-Insunza R, Venegas LF, Iruretagoyena M, et al. Role of dendritic cells in peanut allergy. Expert Rev Clin Immunol. 2018;14(5):367–378.
   PubMed Web of Science ®Google Scholar
• Dioszeghy V, Mondoulet L, Dhelft V, et al. Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice. J Immunol. 2011;186(10):5629–5637.
   PubMed Web of Science ®Google Scholar
• Allam JP, Stojanovski G, Friedrichs N, et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy. 2008;63(6):720–727.
   PubMed Web of Science ®Google Scholar
• Meglio P, Bartone E, Plantamura M, et al. A protocol for oral desensitization in children with IgE-mediated cow’s milk allergy. Allergy. 2004;59(9):980–987.
   PubMed Web of Science ®Google Scholar
• Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow’s milk-induced reactions. J Allergy Clin Immunol. 2008;121(2):343–347.
   PubMed Web of Science ®Google Scholar
• Buchanan AD, Green TD, Jones SM, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol. 2007;119(1):199–205.
   PubMed Web of Science ®Google Scholar
• Varshney P, Jones SM, Scurlock AM, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011;127(3):654–660.
   PubMed Web of Science ®Google Scholar
• AT C, Islam S, King Y, et al. Successful oral tolerance induction in severe peanut allergy. Allergy. 2009;64(8):1218–1220.
   PubMed Web of Science ®Google Scholar
• Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol. 2010;126(1):83–91 e1.
   PubMed Web of Science ®Google Scholar
• Anagnostou K, Islam S, King Y, et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet. 2014;383(9925):1297–1304.
   PubMed Web of Science ®Google Scholar
• Bird JA, Feldman M, Arneson A, et al. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization. J Allergy Clin Immunol Pract. 2015;3(3):433-5e1-3.
   Web of Science ®Google Scholar
• Narisety SD, Frischmeyer-Guerrerio PA, Keet CA, et al. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol. 2015;135(5):1275–82e1-6.
   Web of Science ®Google Scholar
• Bird JA, Spergel JM, Jones SM, et al. Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial. J Allergy Clin Immunol Pract. 2018;6(2):476–85 e3.
   PubMed Web of Science ®Google Scholar
• Investigators P, Vickery BP, Vereda A, et al. AR101 oral immunotherapy for peanut allergy. N Engl J Med. 2018;379(21):1991–2001.
   PubMed Web of Science ®Google Scholar
• Varshney P, Steele PH, Vickery BP, et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol. 2009;124(6):1351–1352.
   PubMed Web of Science ®Google Scholar
• Chu DK, Wood RA, French S, et al. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet. 2019;393(10187):2222–2232.
   PubMed Web of Science ®Google Scholar
• Lucendo AJ, Arias A, Tenias JM. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014;113(6):624–629.
   PubMed Web of Science ®Google Scholar
• Virkud Y, Vickery BP, Steele PH, et al. Predictors of elevated rates of adverse events while on peanut oral immunotherapy. J Allergy Clin Immunol. 2015;135(2):AB156.
   Web of Science ®Google Scholar
• Allam JP, Wurtzen PA, Reinartz M, et al. Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties. J Allergy Clin Immunol. 2010;126(3):638–45 e1.
   PubMed Web of Science ®Google Scholar
• Burks AW, Wood RA, Jones SM, et al. Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol. 2015;135(5):1240–8 e1-3.
   Web of Science ®Google Scholar
• Kim EH, Yang L, Ye P, et al. Long-term sublingual immunotherapy for peanut allergy in children: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol. 2019 Nov;144(5):1320–1326.e1. doi: 10.1016/j.jaci.2019.07.030.
   Google Scholar
• Dioszeghy V, Mondoulet L, Laoubi L, et al. Antigen uptake by langerhans cells is required for the induction of regulatory T cells and the acquisition of tolerance during epicutaneous immunotherapy in OVA-sensitized mice. Front Immunol. 2018;9:1951.
   PubMed Web of Science ®Google Scholar
• Jones SM, Agbotounou WK, Fleischer DM, et al. Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch. J Allergy Clin Immunol. 2016;137(4):1258–61 e10.
   PubMed Web of Science ®Google Scholar
• Purington N, Chinthrajah RS, Long A, et al. Eliciting dose and safety outcomes from a large dataset of standardized multiple food challenges. Front Immunol. 2018;9:2057.
   PubMed Web of Science ®Google Scholar
• Kim EH, Yang L, Ye P, et al. Long-term sublingual immunotherapy for peanut allergy in children: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol. 2019;144:1320–1326.e1.
   Web of Science ®Google Scholar
• Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. 1997;99(6 Pt 1):744–751.
   PubMed Web of Science ®Google Scholar
• Oppenheimer JJ, Nelson HS, Bock SA, et al. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol. 1992;90(2):256–262.
   PubMed Web of Science ®Google Scholar
• van der Kleij HPM, Warmenhoven HJM, van Ree R, et al. Chemically modified peanut extract shows increased safety while maintaining immunogenicity. Allergy. 2019;74(5):986–995.
   PubMed Web of Science ®Google Scholar